These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17447137)

  • 21. Optimizing Hypertensive Acute Heart Failure Management with Afterload Reduction.
    Collins S; Martindale J
    Curr Hypertens Rep; 2018 Feb; 20(1):9. PubMed ID: 29478124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current and novel pharmacological approaches to renal insufficiency in heart failure.
    Hindnavis V; Tang WH
    Minerva Cardioangiol; 2006 Dec; 54(6):753-62. PubMed ID: 17167387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nesiritide: a new drug for the treatment of decompensated heart failure.
    Elkayam U; Akhter MW; Tummala P; Khan S; Singh H
    J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):181-94. PubMed ID: 12232567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing the treatment of heart failure.
    Giles TD
    Curr Opin Cardiol; 1994 Jul; 9 Suppl 1():S21-7. PubMed ID: 7827370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-type natriuretic peptide: spectrum of application. Nesiritide (recombinant BNP) for heart failure.
    Fonarow GC
    Heart Fail Rev; 2003 Oct; 8(4):321-5. PubMed ID: 14574051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical management of mild-to-moderate heart failure before the advent of beta blockers.
    Abraham WT; Wagoner LE
    Am J Med; 2001 May; 110 Suppl 7A():47S-62S. PubMed ID: 11334776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of cardiac failure with vasodilators (author's transl)].
    Imhof P
    Schweiz Rundsch Med Prax; 1978 May; 67(22):219-29. PubMed ID: 418395
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure.
    Elkayam U; Akhter MW; Singh H; Khan S; Usman A
    Am J Cardiol; 2004 Jan; 93(2):237-40. PubMed ID: 14715359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.
    Sackner-Bernstein JD; Kowalski M; Fox M; Aaronson K
    JAMA; 2005 Apr; 293(15):1900-5. PubMed ID: 15840865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure.
    Johnson W; Omland T; Hall C; Lucas C; Myking OL; Collins C; Pfeffer M; Rouleau JL; Stevenson LW
    J Am Coll Cardiol; 2002 May; 39(10):1623-9. PubMed ID: 12020489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitrates for acute heart failure syndromes.
    Wakai A; McCabe A; Kidney R; Brooks SC; Seupaul RA; Diercks DB; Salter N; Fermann GJ; Pospisil C
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD005151. PubMed ID: 23922186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of vasodilator agents in the treatment of heart failure.
    Lloyd EA
    S Afr Med J; 1979 Nov; 56(20):787-95. PubMed ID: 159502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.
    Fajardo J; Heywood JT; Patterson JH; Adams K; Chow SL
    Expert Rev Cardiovasc Ther; 2015; 13(7):743-51. PubMed ID: 26028173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.
    Klein L; O'Connor CM; Gattis WA; Zampino M; de Luca L; Vitarelli A; Fedele F; Gheorghiade M
    Am J Cardiol; 2003 May; 91(9A):18F-40F. PubMed ID: 12729848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nesiritide in acute decompensated heart failure: current status and future perspectives.
    Mohammed SF; Korinek J; Chen HH; Burnett JC; Redfield MM
    Rev Cardiovasc Med; 2008; 9(3):151-8. PubMed ID: 18953274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of dilated cardiomyopathy with digitalis, diuretics and vasodilators].
    Liebau G
    Herz; 1985 Jun; 10(3):138-42. PubMed ID: 2991095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment options for acute decompensated heart failure.
    Southworth MR
    Am J Health Syst Pharm; 2003 Aug; 60 Suppl 4():S7-15. PubMed ID: 12966901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing outcomes in the patient with acute decompensated heart failure.
    Mehra MR
    Am Heart J; 2006 Mar; 151(3):571-9. PubMed ID: 16504617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical advances in the treatment of congestive heart failure.
    Armstrong PW; Moe GW
    Circulation; 1993 Dec; 88(6):2941-52. PubMed ID: 7902784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The treatment of congestive heart failure by using vasodilators. I. Physiological basis. Different vasodilators (author's transl)].
    Solignac A
    Nouv Presse Med; 1978 Mar; 7(12):1013-20. PubMed ID: 96422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.